tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

BCAB Stock Latest News

BioAtla Granted Continued Nasdaq Listing with Conditions
Company AnnouncementsBioAtla Granted Continued Nasdaq Listing with Conditions
9d ago
8K
BCAB
Buy Rating Affirmed for BioAtla Amid Promising Developments and Strategic Partnerships
PremiumRatings
Buy Rating Affirmed for BioAtla Amid Promising Developments and Strategic Partnerships
23d ago
BCAB
BioAtla announces outcomes from Type B FDA meeting on ozuriftamab vedotin
PremiumThe Fly
BioAtla announces outcomes from Type B FDA meeting on ozuriftamab vedotin
24d ago
BCAB
BioAtla downgraded to Market Perform from Outperform at Citizens JMP
PremiumThe Fly
BioAtla downgraded to Market Perform from Outperform at Citizens JMP
2M ago
BCAB
BioAtla’s Earnings Call: Positive Clinical Progress Amid Financial Challenges
PremiumCompany Announcements
BioAtla’s Earnings Call: Positive Clinical Progress Amid Financial Challenges
2M ago
BCAB
BioAtla, Inc. Reports Q2 2025 Financial Results and Clinical Progress
PremiumCompany AnnouncementsBioAtla, Inc. Reports Q2 2025 Financial Results and Clinical Progress
2M ago
BCAB
BioAtla presents data from ongoing dose escalation fo BA3182
Premium
The Fly
BioAtla presents data from ongoing dose escalation fo BA3182
3M ago
BCAB
BioAtla Approves 2025 Corporate Bonus Plan
Premium
Company Announcements
BioAtla Approves 2025 Corporate Bonus Plan
3M ago
8K
BCAB
BioAtla presents Phase 2 Oz-V clinical trial data at ASCO 2025
PremiumThe Fly
BioAtla presents Phase 2 Oz-V clinical trial data at ASCO 2025
4M ago
BCAB
BioAtla Receives Nasdaq Non-Compliance Notice
PremiumCompany Announcements
BioAtla Receives Nasdaq Non-Compliance Notice
5M ago
8K
BCAB
BioAtla, Inc. Reports Q1 2025 Financial Results
PremiumCompany Announcements
BioAtla, Inc. Reports Q1 2025 Financial Results
5M ago
BCAB
Bioatla, Inc. Earnings Call Highlights Clinical Success
PremiumCompany Announcements
Bioatla, Inc. Earnings Call Highlights Clinical Success
5M ago
BCAB
BioAtla files to sell 9.68M shares of common stock for holders
PremiumThe FlyBioAtla files to sell 9.68M shares of common stock for holders
5M ago
BCAB
BioAtla reports Q1 EPS (26c), consensus (29c)
Premium
The Fly
BioAtla reports Q1 EPS (26c), consensus (29c)
5M ago
BCAB
BioAtla announces poster presentations at 2025 AACR meeting
Premium
The Fly
BioAtla announces poster presentations at 2025 AACR meeting
5M ago
BCAB
BioAtla price target lowered to $1 from $5 at Citizens JMP
PremiumThe Fly
BioAtla price target lowered to $1 from $5 at Citizens JMP
6M ago
BCAB
BioAtla’s Earnings Call: Clinical Progress and Strategic Outlook
PremiumCompany Announcements
BioAtla’s Earnings Call: Clinical Progress and Strategic Outlook
6M ago
BCAB
Positive Outlook for BioAtla: Strategic Moves and Promising Developments Signal Potential Upside
PremiumRatings
Positive Outlook for BioAtla: Strategic Moves and Promising Developments Signal Potential Upside
6M ago
BCAB
BioAtla price target lowered to $10 from $13 at BTIG
PremiumThe Fly
BioAtla price target lowered to $10 from $13 at BTIG
6M ago
BCAB
BioAtla, Inc. Reports 2024 Financial Results and Clinical Progress
PremiumCompany AnnouncementsBioAtla, Inc. Reports 2024 Financial Results and Clinical Progress
6M ago
BCAB
BioAtla announces restructuring, to cut over 30% of workforce
Premium
The Fly
BioAtla announces restructuring, to cut over 30% of workforce
6M ago
BCAB
BioAtla reports Q4 Net loss ($14.9M) vs ($26.9M) last year
Premium
The Fly
BioAtla reports Q4 Net loss ($14.9M) vs ($26.9M) last year
6M ago
BCAB

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >